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keeping with right peripheral facial nerve lesion. Laboratory ﬁndings were
consistent with polycythemia rubra vera.
Conclusions: Although Bell’s palsy in our patient may have occurred by
chance, a neuropathic effect of polycythemia rubra vera on the facial
nerve cannot be excluded.
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Background: CIDP is a progressive or relapsing immune mediated disorder
often responsive to corticosetereroids, IV immunoglobulin & plasma
exchange. Hepatitis C is common cause of death in patient having
chronic hepatic disorder & affecting approx. 1 out of 10 20 population
of Pakistan. Hepatitis C may be associated with peripheral neuropathies
mainly axonal, chronic as well as acute cryoglobulinemia, and association
with CIDP is less commonly explained. To date the optimal antiviral
treatment of Hepatitis C viral infection is the combination of peg
interferon-a with ribavarin.
Case report: 44 years old, male with hepatitis C associated CIDP improved
with combination of antiviral therapy like interferon-a and Ribavarin.
Five weeks after starting therapy he felt 80% improvement in symptoms
(muscle power & numbness). Viral eradication was conﬁrmed (HCV
PCR negative) after treatment patient became symptoms free. Repeat
NCS/EMG turned to be normal except absent bilateral H-reﬂex (possibly
secondary to underlying diabetes mellitus.
Conclusions: We described a patient with hepatitis C associated CIDP
that markedly improved with the antiviral therapy. The current case
report may be an initiative to do more studies in the different canters,
particularly in countries where HCV-infection is more common, like in our
country Pakistan.
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Background: Guillain Barre´ Syndrome (GBS) is an important cause of
acute neuropathy. Denervating potentials on needle EMG are hallmark
of axonal damage. However, this is time depentant phenomenon. The
degeneration of axon depends upon length of axon to be degenerated.
Shorter distance will require shorter time similarly denervation also
appear early in this situation. Studies claim variable time duration for
denervation potentials form two weeks to three weeks. This study was
to determine early denervation potentials in axonal GBS.
Methods: We retrospectively reviewed the clinical and neurophysiological
data of GBS patients over a period of three years GBS patients were
classiﬁed according to established neurophysiologic criteria.
Results: Forty-two patients were included, 25 were males and 17
females. Thirteen (30%) had axonal GBS. Out of thirteen ten (10)
underwent early electrodiagnostic study within 14 days and three (3)
after 14 days. 4/10 (40%) had denervation potentials early in the course
of illness (less than fourteen).
Conclusions: Denervation potentials can be seen less than two weeks
duration in axonal GBS. Further large studies are required to establish
whether this has relation to bad outcome in axonal variant of GBS.
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Background: Polyneuropathy and Myopathy are frequently encountered
in the setting of Critical illness patients. Up to 50% of intensive care
unit (ICU) patients show electrophysiological features of either or both
conditions. These conditions interfere with functional recovery and delay
weaning from mechanical ventilation, resulting in excess morbidity,
mortality and cost of care. This study was to deﬁne the clinical spectrum
of critical illness Polyneuropathy (CIP) and Myopathy (CIM) in a setting of
developing country.
Methods: Hospital records spanning the period 2000 through 2005 were
searched with ICD-9 codes to identify patients with CIP and CIM.
Functional improvement was judged by (i) increment of at least 1
grade on the Medical Research Council scale of motor strength: and (ii)
reappearance of deep-tendon reﬂexes.
Results: CIP or CIM was established in 47 patients of these, mean age was
54: mean length of stay in hospital 34 (range 8 100) electrophysiological
studies revealed CIP in 31 patients (66%) CIM in 12 (26%) and a mixed
picture in 4 (8%). Major co-morbid conditions included sepsis (39%) and
diabetes mellitus (17%), with an additional 28% having both and 17%
having either. Neuromuscular blocking drugs were administered to 14
(30%) and steroids to 10 (21%) patients: an additional 11 (23%) patients
received both agents while 12 (26%) patients received neither. In hospital
mortality was 51%. At discharge and follow-up, motor improvement was
seen in 11 (23%) while 12 (26%) remained neurologically unchanged.
Conclusions: We conclude that CIP and CIM are frequent identiﬁable
complications of critical illness in our setting. These observations need
further prospective studies to delineate risk factors and out come
predictors, to improve critical care patients.
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Background: IgG anti-GD1a ganglioside antibody is one of the important
markers of acute motor axonal neuropathy (AMAN) type Guillain Barre´
syndrome (GBS). It is highly associated with disease severity, need for
mechanical ventilation and axonal degeneration of peripheral nerve.
But, there was limited report presented with cranial neuropathy without
signiﬁcant motor weakness. We report a patient manifested as polycranial
neuropathy and sensory ataxia with IgG anti-GD1a antibody without
peripheral neuropathy as a variant of GBS.
Case report:A 46-year-old woman visited with slurred speech, swallowing
difﬁculty and gait disturbance following diarrhea which had developed
since 2 days ago. Neurological examinations revealed enlarged pupils as
5/5 mm with sluggish light reﬂexes. Bilateral facial weaknesses, bulbar
palsy with decreased gag reﬂex and neck ﬂexor weakness were noted.
The deep tendon reﬂexes were lost but motor power was normal in
all extremities. Decreased sensations of vibration and position in distal
limbs were found. She showed ataxic gait with positive Romberg sign.
Laboratory studies including routine chemistry, protein electrophoresis,
rheumatologic proﬁles and cerebral spinal ﬂuid examinations were
normal. IgM and IgG anti-ganglioside antibodies to GM1, GM2, GD1b,
GD3, GT1b, GQ1b and GT1a were all negative except for IgG anti-
GD1a antibody (1:640). Routine nerve conduction study (NCS) including
facial NCS and blink reﬂex test performed at 3rd, 7th and 13th days of
symptoms onset. Blink reﬂex test at 7th day showed compatible ﬁndings
with bilateral facial neuropathy, although other studies couldn’t reveal
any abnormal ﬁnding.
Intravenous immunoglobulin treatment was started (400mg/kg/day for 5
days) and her deﬁcits were improved during 2 weeks of admission. At
3rd months for follow up, she showed complete recovery in neurological
examinations.
Conclusions: Our case showed multiple cranial neuropathies including
facial, bulbar and neck weaknesses in addition to sensory ataxia. These
ﬁndings suggest that GD1a ganglioside might be located at cranial nerves
and sensory nerve root including dorsal root ganglia. This is the ﬁrst case
of GBS with IgG anti-GD1a antibody manifested as polycranial neuropathy
and ataxia.
